Immunotherapy Drug Combination for Treating Metastatic Colorectal Cancer Approved in the EU
Immunotherapy Drug Combination for Treating Metastatic Colorectal Cancer Approved in the EU

Nivolumab & ipilumab combination approved by the EC for MSI-H or dMMR patients with mCRC broadens treatment options

...

Read

DiCE participates at 2021 ESMO-GI
DiCE participates at 2021 ESMO-GI

DiCE presents poster on gastric and oesophageal cancer at ESMO GI international conference

...

Read

DiCE Projects Ensure Patient Involvement in Basic and Clinical Research

Discover our projects bringing patient involvement into basic and clinical cancer research – overviews to be given in our Masterclass

...

Read

All.Can - Cancer Efficiency Resources for DiCE Members
All.Can – Cancer Care Efficiency Resources for DiCE Members

All.Can – Cancer Efficiency Resources for DiCE Members

...

Read

On Biosimilars - Developments in the Path to Affordable and Accessible Healthcare
On Biosimilars – Developments in the Path to Affordable and Accessible Healthcare

Digestive Cancers Europe On Biosimilars – Developments in the Path to Affordable and Accessible Healthcare

...

Read

EMA Approves New Treatment Option for Certain Cholangiocarcinoma Patients
EMA Approves New Treatment Option for Certain Cholangiocarcinoma Patients

Rare Digestive Cancers – EMA Approval of New Treatment Option for Certain Cholangiocarcinoma Patients

...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.